Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Solarant Medical was a medical technology company focused on developing minimally invasive solutions for women's health, specifically targeting stress urinary incontinence (SUI). The company developed the Renessa System, a transurethral radiofrequency (RF) energy device designed to treat SUI in an office-based setting. By delivering controlled heat to the collagen in the bladder neck and proximal urethra, the system triggered a natural healing response that firmed the tissue and reduced leakage. The Renessa procedure offered a non-surgical alternative to traditional suburethral slings, requiring no incisions or general anesthesia. In 2004, Solarant Medical was acquired by American Medical Systems (AMS) to bolster its portfolio of pelvic health treatments.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Solarant Medical.